400
Participants
Start Date
July 1, 2021
Primary Completion Date
October 31, 2023
Study Completion Date
June 30, 2024
Pancreatic Enzyme
CREON micro 5000
Ursodeoxycholic acid
Ursodiol C24H40O4 suspension
Pancreatic Enzyme placebo
Microcrystalline Cellulose,Macrogel 4000, Iron Oxide Yellow, Iron Oxide Red, Activated Charcoal.
Ursodeoxycholic acid placebo
Sodium Citrate Dihydrate, Aspartame, Carboxymethylcellulose Sodium, Citric Acid Monohydrate, Dispersible Cellulose, Glycerol, Polysorbate-80, Saccharin Sodium,Sodium Benzoate, Sodium Methylparaben, Sodium Propylparaben
KEMRI WT Clinical Trials Facility, Kilifi
ICDDR,B Dhaka Hospital, Dhaka
Queen Elizabeth Central Hospital, Blantyre
Mulago Hospital, Kampala
Collaborators (1)
University of Amsterdam
OTHER
University of Toronto
OTHER
University of Washington
OTHER
Oregon Health and Science University
OTHER
Kenya Medical Research Institute
OTHER
Queen Elizabeth Central Hospital, Blantyre, Malawi
UNKNOWN
Makerere University
OTHER
KEMRI-Wellcome Trust Collaborative Research Program
OTHER
International Centre for Diarrhoeal Disease Research, Bangladesh
OTHER
University of Oxford
OTHER